#united therapeutics corporation

1 story

#btig #market capitalization #price target #specialty pharmaceutical #uthr

United Therapeutics Drops 5.2% Despite BTIG Buy Rating
United Therapeutics shares fell 5.2% Friday as BTIG upgraded to buy with $728 target.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m